126 related articles for article (PubMed ID: 20802100)
21. The immunoglobulins of the cat.
Barlough JE; Jacobson RH; Scott FW
Cornell Vet; 1981 Oct; 71(4):397-407. PubMed ID: 6797789
[No Abstract] [Full Text] [Related]
22. Prevalence and monitoring of oligosecretory myeloma.
Larson D; Kyle RA; Rajkumar SV
N Engl J Med; 2012 Aug; 367(6):580-1. PubMed ID: 22873553
[No Abstract] [Full Text] [Related]
23. IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma.
Boyle EM; Fouquet G; Guidez S; Bonnet S; Demarquette H; Dulery R; Herbaux C; Noel MP; Manier S; Schraen S; Onraed B; Faucompré JL; Hennache B; Petillon MO; Mathiot C; Avet-Loiseau H; Facon T; Harding SJ; Moreau P; Leleu X
Cancer; 2014 Dec; 120(24):3952-7. PubMed ID: 25116271
[TBL] [Abstract][Full Text] [Related]
24. Early free light chain reduction following treatment initiation predicts favorable outcome in intact immunoglobulin myeloma.
Claveau JS; Savary Bélanger S; Ahmad I; Delisle JS; De Guire V; Roy J; LeBlanc R
Blood Cancer J; 2022 Jan; 12(1):3. PubMed ID: 34987163
[No Abstract] [Full Text] [Related]
25. [IgM multiple myeloma].
Calvo Villas J; Ramírez Sánchez M; Sicilia Guillén F
Sangre (Barc); 1997 Jun; 42(3):257-8. PubMed ID: 9381279
[No Abstract] [Full Text] [Related]
26. Protein electrophoresis and serum free light chains in the diagnosis and monitoring of plasma cell disorders: laboratory testing and current controversies.
Tate JR; Graziani MS; Mollee P; Merlini G
Clin Chem Lab Med; 2016 Jun; 54(6):899-905. PubMed ID: 27107838
[No Abstract] [Full Text] [Related]
27. Monitoring IgA multiple myeloma: immunoglobulin heavy/light chain assays.
Katzmann JA; Willrich MA; Kohlhagen MC; Kyle RA; Murray DL; Snyder MR; Rajkumar SV; Dispenzieri A
Clin Chem; 2015 Feb; 61(2):360-7. PubMed ID: 25451866
[TBL] [Abstract][Full Text] [Related]
28. Correlation of serum immunoglobulin free light chain quantification with urinary Bence Jones protein in light chain myeloma.
Abraham RS; Clark RJ; Bryant SC; Lymp JF; Larson T; Kyle RA; Katzmann JA
Clin Chem; 2002; 48(4):655-7. PubMed ID: 11901068
[No Abstract] [Full Text] [Related]
29. Benefits of new immunoglobulin-derived biomarkers for the diagnosis and follow-up of patients with dysglobulinemia.
Ermak N; Nguyen-Khoa T; Alyanakian MA
Ann Biol Clin (Paris); 2016 Oct; 74(5):597-605. PubMed ID: 27707674
[TBL] [Abstract][Full Text] [Related]
30. [IgD myeloma. Considerations about its diagnosis based on three cases (author's transl)].
López-Aldeguer J; Redón J; González-Molina J; Benedito M; Herranz C; Lacruz J; Navarro JR; Caballero M
Sangre (Barc); 1981; 26(6):1139-44. PubMed ID: 6805083
[No Abstract] [Full Text] [Related]
31. [Diagnostic problem in a case of micromolecular myeloma].
Pizzolato MA; Goñi FR; Reicherstorfer EV; Massot JE; de María HE; Burucúa JE
Medicina (B Aires); 1979; 39(3):384-8. PubMed ID: 117277
[No Abstract] [Full Text] [Related]
32. The utility of the serum heavy/light chain assay as a complementary tool in the monitoring of patients with plasma cell myeloma: a report of three cases.
Kim H; Lee JK; Hong YJ; Hong SI; Shin DY; Kang HJ; Chang YH
Ann Clin Lab Sci; 2015; 45(2):193-8. PubMed ID: 25887874
[TBL] [Abstract][Full Text] [Related]
33. Bence-Jones proteins and light chains of immunoglobulins (second of two parts).
Solomon A
N Engl J Med; 1976 Jan; 294(2):91-8. PubMed ID: 53788
[No Abstract] [Full Text] [Related]
34. Using mass spectrometry to monitor monoclonal immunoglobulins in patients with a monoclonal gammopathy.
Barnidge DR; Dasari S; Botz CM; Murray DH; Snyder MR; Katzmann JA; Dispenzieri A; Murray DL
J Proteome Res; 2014 Mar; 13(3):1419-27. PubMed ID: 24467232
[TBL] [Abstract][Full Text] [Related]
35. IgD myeloma or delta heavy-chain disease?
Vladutiu AO
Clin Chem; 1980 Feb; 26(2):353-4. PubMed ID: 6766363
[No Abstract] [Full Text] [Related]
36. Comparison of mass spectrometry and flow cytometry in measuring minimal residual disease in multiple myeloma.
Foureau D; Bhutani M; Guo F; Rigby K; Leonidas M; Tjaden E; Fox A; Atrash S; Paul B; Voorhees PM; Usmani SZ
Cancer Med; 2021 Oct; 10(20):6933-6936. PubMed ID: 34494717
[TBL] [Abstract][Full Text] [Related]
37. [Non-secretory myeloma of heavy mu-chain type].
Leglise MC; Briere J; Abgrall JF; Hurez D
Nouv Rev Fr Hematol (1978); 1983; 25(2):103-6. PubMed ID: 6408608
[TBL] [Abstract][Full Text] [Related]
38. Specificity of serum and urine protein electrophoresis for the diagnosis of monoclonal gammopathies.
Katzmann JA; Stankowski-Drengler TJ; Kyle RA; Karen SL; Snyder MR; Lust JA; Dispenzieri A
Clin Chem; 2010 Dec; 56(12):1899-900. PubMed ID: 20844060
[No Abstract] [Full Text] [Related]
39. Challenges of measuring monoclonal proteins in serum.
Keren DF; Schroeder L
Clin Chem Lab Med; 2016 Jun; 54(6):947-61. PubMed ID: 26910744
[TBL] [Abstract][Full Text] [Related]
40. [Myeloma and immunoglobins (author's transl)].
Ohtani H
Rinsho Byori; 1976 Apr; 24(4):287-93. PubMed ID: 819681
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
